Form 4: AtriCure Director Robert S. White Acquires Shares Through Restricted Stock Award

Director Robert S. White acquired 7,788 shares of AtriCure, Inc. through a restricted stock award, vesting in one year.

Summary

• Robert S. White, a director of AtriCure, Inc., acquired 7,788 shares of common stock on May 13, 2024.
• The acquisition was made through a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan.
• These shares will vest on the one-year anniversary of the grant date.
• Following the transaction, White beneficially owns 96,773 shares of AtriCure common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reflects a standard transaction of stock acquisition by a director. It's neither overwhelmingly positive nor negative.

Positives

• A director's acquisition of shares can be seen as a positive sign, indicating confidence in the company's future prospects.

Future Outlook

The acquired shares will vest upon the one-year anniversary of the grant date, indicating a future incentive for the director.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC when a company insider, such as a director, buys or sells shares in their own company. It provides transparency to the market regarding insider transactions.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment due to the director's increased stake in the company.

Key Dates